FidoCure
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
228 Hamilton Ave, Palo Alto, California,...Website
www.fidocure.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About FidoCure
FidoCure is a pioneering service that transforms canine cancer treatment through personalized medicine, utilizing genomic testing to tailor therapies for dogs. The company aims to provide effective cancer treatment options beyond traditional chemotherapy and radiation, focusing on the unique genetic profiles of each dog. Their services are designed for veterinarians and pet parents, offering hope and improved prognoses for dogs diagnosed with cancer. FidoCure combines scientific research and innovation to create the largest proprietary cancer data set in the world, enhancing the understanding and treatment of canine cancers.Explore more
FidoCure Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is FidoCure your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if FidoCure has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when FidoCure launches new products
Congratulate Masked Content for being promoted to Masked Content at FidoCure
Check out if FidoCure is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once FidoCure has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
FidoCure, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if FidoCure had a recent Job posting/layoffs
Earning: See what the market has to say on FidoCure recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to FidoCure
Compare insights from companies similar to FidoCure, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
FidoCure is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
FidoCure is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about FidoCure.
FidoCure financials insights
Gather financial insights about FidoCure, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Other Financing Round
$10M
FidoCure Tech Stack
A closer look at the technologies used by FidoCure
Most Recent Scoops
Event
Project
Product Marketing, Product Management, Digital Technology, Event Marketing, Doctors / Physicians, Medical Research, Pharmaceuticals, Artificial Intelligence, Field Marketing, Healthcare Technology, Marketing Strategy
Project
Product Development, Product Management, Legal Affairs, Artificial Intelligence, Healthcare Technology
Lateral Move
Executive Move
Chase Schwalbach has been appointed as Chief Product Officer.
Funding
FidoCure News & Media
FidoCure Unleashes Fetch™: AI Engine Analyzes Real-World Evidence To Optimize Cancer Therapies for Dogs
PALO ALTO, Calif.--(BUSINESS WIRE)--FidoCure, a leader in precision oncology for dogs, launched Fetch™, its proprietary artificial intelligence engine. As dogs increasingly become cherished family members, they face a critical challenge: cancer remains the leading cause of death, with few therapeutic options available. Through Fetch, FidoCure aims to address this problem by analyzing large datasets of real-world canine cancer cases to identify promising therapies for dogs with cancer. Fetch anaFidoCure To Unveil Breakthrough in Canine Hemangiosarcoma at 2024 Veterinary Cancer Society Annual Conference
PALO ALTO, Calif.--(BUSINESS WIRE)--FidoCure, a leader in AI-driven precision oncology for dogs, is excited to share landmark findings on canine splenic hemangiosarcoma at the 2024 Veterinary Cancer Society (VCS) Annual Conference. This research advances the fight against the most prevalent and deadly canine cancer. The VCS Conference, the largest and most prestigious event in veterinary oncology with over 1,400 attendees, showcases advancements in animal cancer treatment and research. "We areNovel, targeted canine cancer therapy receives US patent - DVM360
FidoCure used AI technology to aid in the development of the new oncology drugFidoCure Receives Patent for AI-Driven Drug Development, Accelerating a Novel Portfolio of Precision Therapeutic for Cancer
PALO ALTO, Calif.--(BUSINESS WIRE)--FidoCure receives a patent for AI-driven drug development, signifying a pivotal shift in animal and human health.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding FidoCure
Sign Up For FreeTo access detailed company insights
FidoCure is a pioneering service that transforms canine cancer treatment through personalized medicine, utilizing genomic testing to tailor therapies for dogs. The company aims to provide effective cancer treatment options beyond traditional chemotherapy and radiation, focusing on the unique genetic profiles of each dog. Their services are designed... Read More
